Total Knee Arthroplasty Utilizing Adductor Canal Block: Effect on Quadriceps Sparing
Postoperative Pain Management Following Total Knee Arthroplasty Utilizing Adductor Canal Block: Effects on Pain Management and Quadriceps Sparing
1 other identifier
interventional
33
1 country
1
Brief Summary
The purpose of this study is to investigate whether there is quantitative motor-sparing of the quadriceps muscles following adductor canal nerve block versus femoral nerve block. Patients will be randomly placed into one of three treatment groups: 1) Femoral nerve block, 2) Adductor canal nerve block - low volume, or 3) Adductor canal nerve block - high volume. Quadriceps function will be assessed in the operating room using a skin patch and electrical stimulation. Follow up visits with the patients will continue over the course of 2 days during patient's stay at the hospital. A total of 60 patients will be enrolled for the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 28, 2014
CompletedFirst Posted
Study publicly available on registry
March 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 2, 2016
January 1, 2015
1.8 years
February 28, 2014
January 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quadriceps function as assessed by non-invasive transcutaneous nerve stimulation of the femoral nerve
After CSE effect, but prior to peripheral block, quadriceps function will be assessed by non-invasive transcutaneous nerve stimulation of the femoral nerve by placing an ECG electrode over the femoral location (determined by U/S) in the inguinal groove. The threshold amperage that produces patellar motion in response to electrical stimulation will be recorded. This threshold amperage will serve as a baseline value. Following the peripheral nerve block, transcutaneous stimulation will be repeated and, if still possible to elicit quadriceps contractions in response to electrical stimulation, the resulting new threshold amperage will be measured. The new threshold amperage will be expressed as a percentage of the baseline value and serve as a quantitative functional indication of the extent of quadriceps paresis resulting from the peripheral nerve block. The primary outcome will be quadriceps paralysis - yes/no.
15 minutes after the placement of the peripheral nerve block (femoral or adductor canal)
Secondary Outcomes (3)
Threshold amperage as a percentage of the baseline value
15 minutes after the placement of the peripheral nerve block
Analgesic adequacy
Resolution of the spinal anesthetic (2 hours post-op), 24 and 48 hours post-op
Ability to complete a straight leg lift
Holding area (baseline), at spinal resolution (2 hours post-op), 24 hours post-op and 48 hours post-op
Study Arms (3)
High volume Adductor canal block
EXPERIMENTALAdductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of 30 mL 0.25% bupivacaine/ epinephrine
Low volume Adductor Canal Block
EXPERIMENTALAdductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of of 10 mL 0.75% bupivacaine/ epinephrine
Femoral nerve block
EXPERIMENTALFemoral nerve block with 10 mL 0.75 % bupivacaine/epinephrine
Interventions
Adductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of 30 mL 0.25% bupivacaine/ epinephrine
Adductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of of 10 mL 0.75% bupivacaine/ epinephrine
Femoral nerve block with 10 mL 0.75 % bupivacaine/epinephrine
Eligibility Criteria
You may qualify if:
- All patients undergoing primary unilateral total knee arthroplasty
- Planned use of combined spinal epidural (CSE) anesthesia
- Ability to follow study protocol
You may not qualify if:
- Contraindication to a spinal or epidural anesthetic
- Chronic opioid use (defined as daily or almost daily use of opioids for \>3 months)
- Allergy to local anesthetics
- Pre-existing neuropathy or weakness of the operative limb
- Any neuromuscular disorder
- Diabetes type I and II
- Contraindication to a femoral nerve block or adductor canal nerve block
- Allergy or intolerance to any of the study medications
- BMI \> 35 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital for Special Surgery
New York, New York, 10021, United States
Related Publications (2)
Vloka JD, Hadzic A, Lesser JB, Kitain E, Geatz H, April EW, Thys DM. A common epineural sheath for the nerves in the popliteal fossa and its possible implications for sciatic nerve block. Anesth Analg. 1997 Feb;84(2):387-90. doi: 10.1097/00000539-199702000-00028.
PMID: 9024035RESULTDavis JJ, Bond TS, Swenson JD. Adductor canal block: more than just the saphenous nerve? Reg Anesth Pain Med. 2009 Nov-Dec;34(6):618-9. doi: 10.1097/AAP.0b013e3181bfbf00. No abstract available.
PMID: 19901788RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Urmey, MD
Hospital for Special Surgery, New York
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2014
First Posted
March 7, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
February 2, 2016
Record last verified: 2015-01